Normal view MARC view ISBD view

Acetaminophen : (Record no. 56521)

MARC details
000 -LEADER
fixed length control field	05888cam a2200745 i 4500
001 - CONTROL NUMBER
control field	on1162283471
003 - CONTROL NUMBER IDENTIFIER
control field	OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field	20201015085811.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field	m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field	cr \|\|\|\|\|\|\|\|\|\|\|
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field	120622s2012 nyua ob 001 0 eng
010 ## - LIBRARY OF CONGRESS CONTROL NUMBER
LC control number	2019714237
040 ## - CATALOGING SOURCE
Original cataloging agency	DLC
Language of cataloging	eng
Description conventions	rda
Transcribing agency	DLC
Modifying agency	OCLCF
--	VLY
--	OCLCO
--	YDX
--	YDXCP
--	N$T
--	E7B
--	EBLCP
--	DEBSZ
--	AGLDB
--	VTS
--	STF
--	AU@
--	K6U
019 ## -
--	828140617
--	923652949
--	1138136602
--	1140692480
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	9781619423756
Qualifying information	ebook
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number	1619423758
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN	161942374X
Qualifying information	hbk.
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN	9781619423749
Qualifying information	hbk.
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier	AU@
System control number	000051707029
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier	DEBBG
System control number	BV041049670
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier	DEBBG
System control number	BV043774727
029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC)
OCLC library identifier	DEBSZ
System control number	472770799
035 ## - SYSTEM CONTROL NUMBER
System control number	(OCoLC)1162283471
Canceled/invalid control number	(OCoLC)828140617
--	(OCoLC)923652949
--	(OCoLC)1138136602
--	(OCoLC)1140692480
050 00 - LIBRARY OF CONGRESS CALL NUMBER
Classification number	RM666.A19
060 #4 - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number	QV 95
072 #7 - SUBJECT CATEGORY CODE
Subject category code	MED
Subject category code subdivision	093000
Source	bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number	615.783
049 ## - LOCAL HOLDINGS (OCLC)
Holding library	MAIN
245 00 - TITLE STATEMENT
Title	Acetaminophen :
Remainder of title	properties, clinical uses, and adverse effects /
Statement of responsibility, etc.	Atash Javaherian and Pasha Latifpour, editors.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture	New York :
Name of producer, publisher, distributor, manufacturer	Nova Biomedical/Nova Science Publishers, Incorporated,
Date of production, publication, distribution, manufacture, or copyright notice	[2012]
300 ## - PHYSICAL DESCRIPTION
Extent	1 online resource.
336 ## - CONTENT TYPE
Content type term	text
Content type code	txt
Source	rdacontent
337 ## - MEDIA TYPE
Media type term	computer
Media type code	c
Source	rdamedia
338 ## - CARRIER TYPE
Carrier type term	online resource
Carrier type code	cr
Source	rdacarrier
490 1# - SERIES STATEMENT
Series statement	Public health in the 21st century series
490 1# - SERIES STATEMENT
Series statement	Nova biomedical
490 1# - SERIES STATEMENT
Series statement	Pharmacology--research, safety testing and regulation
504 ## - BIBLIOGRAPHY, ETC. NOTE
Bibliography, etc. note	Includes bibliographical references and index.
588 ## - SOURCE OF DESCRIPTION NOTE
Source of description note	Description based on print version record.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note	""ACETAMINOPHEN ""; ""ACETAMINOPHEN ""; ""CONTENTS ""; ""PREFACE ""; ""ACETAMINOPHEN (PARACETAMOL): PROPERTIES, CLINICAL USES, AND ADVERSE EFFECTS""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PROPERTIES ""; ""2.1. Chemistry ""; ""2.2. Pharmacokinetics ""; ""2.2.1. Absorption ""; ""2.2.1.1. Immediate Release ""; ""2.2.1.2. Extended Release ""; ""2.2.1.3. Intravenous ""; ""2.2.2. Distribution ""; ""2.2.2.1. Spinal Fluid""; ""2.2.2.2. Placental Barrier ""; ""2.2.2.3. Breast Milk ""; ""2.2.3. Metabolism ""; ""2.2.4. Elimination ""; ""2.2.5. Fetus, Neonates, Infants, and Children""
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note	""2.2.6. Geriatric """"3. CLINICAL USES ""; ""3.1. Antipyresis ""; ""3.2. Analgesia ""; ""4. SPECIAL POPULATIONS ""; ""4.1. Chronic Liver Disease ""; ""4.2. Renal Disease ""; ""4.3. Calorie Restricted Patients ""; ""4.4. HIV ""; ""4.5. Gilbert�a�?s Syndrome ""; ""5. ADVERSE EVENTS ""; ""5.1. Allergy and Hypersensitivity ""; ""5.2. Central Nervous System ""; ""5.3. Gastrointestinal ""; ""5.4. Hemotologic and Hemostatic ""; ""5.5. Hepatic Toxicity ""; ""5.6. Pregnancy and Lactation ""; ""5.7. Renal ""; ""6. DDIS ""; ""6.1. Overdose ""; ""6.1.1. NAC Treatment ""
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note	""7. ACETAMINOPHEN FORMULATIONS """"7.1. Combinations ""; ""7.2. IV Formulation ""; ""CONCLUSION ""; ""REFERENCES ""; ""CLINICAL AND EXPERIMENTAL RELEVANCE OF HYPOTHERMIA IN ACETAMINOPHEN HEPATOTOXICITY ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. APAP-INDUCED HEPATOTOXICITY IN PATIENTS WITH ALF""; ""3. APAP-INDUCED HEPATOTOXICITY IN EXPERIMENTAL MODELS""; ""3.a. Determinants of APAP-Induced Hepatotoxicity in Experimental Animal Models ""; ""3.b. Histopathology ""; ""4. MECHANISMS OF APAP-INDUCED LIVER INJURY ""; ""5. BODY TEMPERATURE, APAP AND THE LIVER ""
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note	""5.a. Reduction of Body Temperature Due to APAP in Humans """"5.b. Reduction of Body Temperature in Experimental Animal Models of Liver Injury""; ""6. RELEVANCE OF BODY TEMPERATURE FOR APAP-INDUCED ALF ""; ""6.1. Effects of Hypothermia on the Development of Brain Edema and Intracranial Hypertension in ALF""; ""6.2. Effects of Hypothermia on the Progression of Liver Injury""; ""CONCLUSIONS ""; ""REFERENCES ""; ""NOVEL APPLICATIONS OF ACETAMINOPHEN ""; ""ABSTRACT ""; ""1.INTRODUCTION ""; ""2. CHRONIC ACETAMINOPHEN INGESTION CAN IMPROVE BLOOD GLUCOSE CONTROL ""
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note	""3. LONG TERM ACETAMINOPHEN INGESTION CAN IMPROVE SKELETAL MUSCLE STRUCTURE AND FUNCTION""""4. ACETAMINOPHEN POSSESSES CARDIOPROTECTIVE AND NEUROPROTECTIVE PROPERTIES ""; ""5. ACETAMINOPHEN EXHIBITS POTENT ANTIOXIDANT ACTIVITY ""; ""CONCLUSIONS AND PERSPECTIVES ""; ""CONFLICT OF INTEREST STATEMENT ""; ""ACKNOWLEDGMENTS ""; ""REFERENCES ""; ""ADVANCED METHODS FOR THE REMOVAL OF ACETAMINOPHEN FROM WATER ""; ""ABSTRACT ""; ""1. INTRODUCTION ""; ""2. PHARMACEUTICALS AS EMERGENT POLLUTANTS ""; ""3. ACETAMINOPHEN IN WATER RESOURCES ""; ""4. ACETAMINOPHEN REMOVAL AND DEGRADATION ""
546 ## - LANGUAGE NOTE
Language note	English.
590 ## - LOCAL NOTE (RLIN)
Local note	eBooks on EBSCOhost
Provenance (VM) [OBSOLETE]	EBSCO eBook Subscription Academic Collection - Worldwide
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Acetaminophen.
Authority record control number or standard number	http://id.loc.gov/authorities/subjects/sh85000454
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Acetaminophen.
Source of heading or term	fast
Authority record control number or standard number	(OCoLC)fst00795571
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Analgesics.
Source of heading or term	fast
Authority record control number or standard number	(OCoLC)fst00808271
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	Acetaminophen.
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element	MEDICAL
General subdivision	Pain Medicine.
Source of heading or term	bisacsh
655 #4 - INDEX TERM--GENRE/FORM
Genre/form data or focus term	Electronic books.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Javaherian, Atash,
Relator term	editor of compilation.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name	Latifpour, Pasha,
Relator term	editor of compilation.
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information	Print version:
Title	Acetaminophen
Place, publisher, and date of publication	New York : Nova Biomedical/Nova Science Publishers, Inc., [2012]
International Standard Book Number	9781619423749 (hbk.)
Record control number	(DLC) 2012405393
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title	Public health in the 21st century series.
Authority record control number or standard number	http://id.loc.gov/authorities/names/n2010180172
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title	Nova biomedical.
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title	Pharmacology-research, safety testing, and regulation series.
Authority record control number or standard number	http://id.loc.gov/authorities/names/n2010180130
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier	<a href="https://libproxy.firstcity.edu.my:8443/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540919">https://libproxy.firstcity.edu.my:8443/login?url=http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=540919</a>
938 ## -
--	ProQuest Ebook Central
--	EBLB
--	EBL3017731
938 ## -
--	ebrary
--	EBRY
--	ebr10654702
938 ## -
--	EBSCOhost
--	EBSC
--	540919
938 ## -
--	YBP Library Services
--	YANK
--	7252232
994 ## -
--	92
--	MYFCU

No items available.